Nuvo Pharmaceuticals Inc.

Status: Publicly traded

Direct answer

Nuvo Pharmaceuticals Inc. is publicly traded on TSX under the ticker MRV.TO.

Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous...

Can you invest in Nuvo Pharmaceuticals Inc.?

Yes. Nuvo Pharmaceuticals Inc. is publicly traded on TSX under the ticker MRV.TO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Nuvo Pharmaceuticals Inc.

Detailed equity research is provided by MarketSnap.